Matthew Evison (Manchester, United Kingdom), Dragana M. Jovanović (Beograd, Republic of Serbia)
Equal efficacy of gefitinib in chemonaive lung adenocarcinoma patients with either exon 19 deletion or L858R point mutation
Chou-Han Lin (Taipei, Taiwan), Chou-Han Lin, Chao-Chi Ho
|   |
Lung adenocarcinoma mimicking interstitial lung disease showed good response to navelbine monotherapy
Yeonhee Park (Daejeon, Republic of Korea), Yeonhee Park, Myoung-Rin Park, Dong-Il Park, Chae-Uk Chung, Jae-Young Moon, Jeong-Eun Lee, Hee-sun Park, Sung-su Jung, Sun-young Kim, Ju-Ock Kim
| |
Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC)
Jana Skřičková (Brno, Czech Republic), Jana Skricková, Zbynek Bortlicek, Karel Hejduk, Milos Pesek, Vitezslav Kolek, Marcela Tomiskova, Ivona Grygarkova, Leona Koubkova, Marketa Cernovska, Jaromir Roubec, Frantisek Salajka, Milada Zemanova, Helena Coupkova, Monika Satankova, Milosalav Marel
| |
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Chai Chee Shee (Petaling Jaya, Malaysia), Chai Chee Shee, Liam Chong Kin, Pang Yong Kek, Kow Keng Siong, Poh Mau Ern, Wong Chee Kuan, Tan Jiunn Liang
| |
Chemotherapy toxicity in advanced non-small cell lung cancer and its impact on survival
Hela Cherif (Tunis, Tunisia), Hela Cherif, Saoussen Bacha, Sonia Habibech, Hager Racil, Sana Cheikhrouhou, Naouel Chaouech, Abdellatif Chabbou, Mohamed Lamine Megdiche
| |
Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
Shinpei Tsuchida (Miyazaki-shi, Japan), Shinpei Tsuchida, Hironobu Tsubouchi, Akiko Kitamura, Nobuhiro Matsumoto, Masamitsu Nakazato
| |
Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
Berna Kömürcüoğlu (Izmir, Turkey), Berna Kömürcüoglu, Yelda Vatansever, Esra Korkmaz, Aysen Evkan, Enver Yalniz
| |
Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease
Achim Rittmeyer (Immenhausen, Germany), Achim Rittmeyer, Birgit Zwerger, Reinhardt Christian, Josef Rüschoff, Hans-Ulrich Schildhaus, Stefan Andreas
| |
Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab
Stefan Rüdiger (Ulm, Germany), Stefan Rudiger, Cornelia Kropf-Sanchen, Gerlinde Schmidtke-Schrezenmeier, Marta Aksentiy, Katja Hoss, Wolfgang Rottbauer
| |
What predicts radiation pneumonitis best? Pulmonary injury after curatively intended radiotherapy of early-stage lung cancer
Janna Berg (Porsgrunn, Norway), Janna Berg, May-Bente Bengtson, Odd Terje Brustugun, Åslaug Helland
| |
Early surgical resection for stage I high-grade neuroendocrine caricinoma of lung
Eisuke Mochizuki (Shizuoka, Japan), Eisuke Mochizuki, Kyohei Ooishi, Koichi Miyashita, Koshiro Ichijyo, Syunya Furukawa, Miyuki Nagaoka, Syun Matsuura, Shinichiro Mikura, Masaru Tsukui, Naoki Koshimizu
| |
Management of residual pleural space and persistent airleak after major lung resection
Kalliopi Athanassiadi (Athens, Greece), Kalliopi Athanassiadi, Ioannis Alevizakis, Nikolaos Papakonstantinou, Stamatios Kakaris
| |
Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC)
Emma Denneny (Harlow, United Kingdom), Emma Denneny, Sarah Clarke, Ravi Ragatha, Samir Naik, Peter Russell, Nick Panagiotopoulos, David Lawrence, Ugo Ekeowa
| |
Evaluation of response to chemotherapy with fiberoptic bronchoscopy in lung cancers
Krsto Jandric (Banja Luka, Bosnia and Herzegovina), Krsto Jandric, Sanja Glisic, Olivera Ljuboja
| |
Lung cancer revisited – CT scan and bronchoscopy concordance after treatment
Cláudia Sofia Vaz Guerreiro (Faro, Portugal), Cláudia Sofia Vaz Guerreiro, Jorge Dionísio, José Duro da Costa
| |
Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients
Wang Yng Lim (York, United Kingdom), Wang Yng Lim, Sam Roberts, Claire Exley, Llinos Jones
| |
A case with a primary adrenal insufficiency secondary to nivolumab
Tuncay Göksel (Izmir, Turkey), Nur Sinem Sengoz Coskun, Ilgin Yildirim Simsir, Tuncay Göksel
| |
LATE-BREAKING ABSTRACT: Early relapse of non-small cell lung cancer (NSCLC) found after CNS-symptoms
Niels-Chr. G. Hansen (Odense C, Denmark), Niels-Chr. G. Hansen, Christian B. Laursen, Stefan S. Jeppesen, Erik Jakobsen
| |